Page 4 - தைராய்டு ஹார்மோன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zydus Cadila gets USFDA nod for thyroid drug SECTIONS Last Updated: Jan 23, 2021, 12:07 PM IST Share Synopsis Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing. iStock Representative Image New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to treat underactive thyroid. Liothyronine is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally made by the thyroid gland.

New delhiZydus cadilaDrug administrationLiothyronine sodiumCadila healthcareUs food and drug administrationThyroid hormoneUnderactive thyroidபுதியது டெல்ஹிஜய்துச் காடிலாகாடிலா சுகாதாரம்தைராய்டு ஹார்மோன்